Michael X. Yang - Fremont CA Karl Littau - Palo Alto CA Steven A. Chen - Fremont CA Henry Ho - San Jose CA Ying Yu - Cupertino CA
Assignee:
Applied Materials, Inc. - Santa Clara CA
International Classification:
H01L 2102
US Classification:
438791, 438584, 438680, 438758, 438774, 438775
Abstract:
The invention provides methods and apparatuses of forming a silicon nitride layer on a semiconductor wafer. A semiconductor wafer is located on a susceptor within a semiconductor processing chamber. A carrier gas, a nitrogen source gas, and a silicon source gas are introduced into the semiconductor processing chamber and a semiconductor wafer is exposed to the mixture of gases at a pressure in the chamber in the range of approximately 100 to 500 Torr.
Wafer Scrubbing Device Having Brush Assembly And Mounting Assembly Forming Spherical Joint
John M White - Hayward CA Ying Yu - Cupertino CA Michael Sugarman - San Francisco CA
Assignee:
Applied Materials, Inc. - Santa Clara CA
International Classification:
B08B 104
US Classification:
15 77, 15 883, 15 211, 15179, 4033221, 403325
Abstract:
A brush mounting system for a wafer scrubbing device includes a brush mandrel and a mounting assembly on which the brush mandrel is mounted. The mounting assembly includes a mounting member adapted to be mounted to a wall of the wafer scrubbing device, and a bearing secured to the mounting member. A brush support is rotatably mounted on the bearing and has an outer end that includes a contact surface adapted to contact the brush mandrel. The contact surface has a spherical profile. The brush mandrel includes a corresponding contact surface having a spherical profile, so that the brush mandrel and the mounting assembly form a spherical joint at the point of contact.
Process For Preparing An Intermediate To Opioid Receptor Antagonists
Pierre-Jean Colson - San Francisco CA, US Ying Yu - Sunnyvale CA, US Daniel D. Long - San Francisco CA, US Ioanna Stergiades - San Francisco CA, US
Assignee:
Theravance, Inc. - San Francisco CA
International Classification:
C07D 209/52
US Classification:
548452
Abstract:
The invention provides an efficient method for preparing 3-endo-(8-azabicyclo[3. 2. 1]oct-3-yl)benzamide by hydrogenation, under controlled conditions, of an amino-protected 3-(8-azabicyclo[3. 2. 1]oct-2-en-3-yl)benzamide intermediate in which the amino-protecting group is removable by catalytic hydrogenation.
Regulating Expression Of Transient Receptor Potential Channel Genes
The present invention relates to compositions related to a polynucleotide encoding a transient receptor potential channel gene. Also disclosed is the use of this polynucleotide, its homologs, fragments, variants and its resultant polypeptides in the diagnosis, prevention and treatment of disease, particularly idiopathic pulmonary arterial hypertension (IPAH). This invention also teaches the use of these polynucleotides and polypeptides as assays for drug discovery and therapies.
3-Carboxypropyl-Aminotetralin Derivatives And Related Compounds As Mu Opioid Receptor Antagonists
Sean G. Trapp - San Francisco CA, US Michael R. Leadbetter - San Leandro CA, US Daniel D. Long - San Francisco CA, US John R. Jacobsen - San Mateo CA, US Priscilla Van Dyke - San Francisco CA, US Pierre-Jean Colson - San Francisco CA, US Miroslav Rapta - Sunnyvale CA, US Ying Yu - Sunnyvale CA, US
Assignee:
Theravance, Inc. - South San Francisco CA
International Classification:
C07C 229/00 C07C 62/00 C07C 65/00
US Classification:
560 45, 562466
Abstract:
The invention provides 3-carboxypropyl-aminotetralin compounds of formula (I):.
Process For Preparing An Intermediate To Mu Opioid Receptor Antagonists
Pierre-Jean Colson - San Francisco CA, US Ying Yu - Sunnyvale CA, US Daniel D. Long - San Francisco CA, US Ioanna Stergiades - San Francisco CA, US
Assignee:
Theravance, Inc. - South San Francisco CA
International Classification:
C07D 451/02
US Classification:
546124
Abstract:
The invention provides an efficient method for preparing 3-endo-(8-azabicyclo[3. 2. 1]oct-3-yl)benzamide by hydrogenation, under controlled conditions, of an amino-protected 3-(8-azabicyclo[3. 2. 1]oct-2-en-3-yl)benzamide intermediate in which the amino-protecting group is removable by catalytic hydrogenation.
Process For Preparing An Intermediate To Mu Opioid Receptor Antagonists
Pierre-Jean Colson - San Francisco CA, US Ying Yu - Sunnyvale CA, US Daniel D. Long - San Francisco CA, US Ioanna Stergiades - San Francisco CA, US
Assignee:
Theravance, Inc. - South San Francisco CA
International Classification:
C07D 451/02
US Classification:
546124
Abstract:
The invention provides an efficient method for preparing 3-endo-(8-azabicyclo[3. 2. 1]oct-3-yl)benzamide by hydrogenation, under controlled conditions, of an amino-protected 3-(8-azabicyclo[3. 2. 1]oct-2-en-3-yl)benzamide intermediate in which the amino-protecting group is removable by catalytic hydrogenation.
3-Carboxypropyl-Aminotetralin Derivatives And Related Compounds As Mu Opioid Receptor Antagonists